Investors and Media
Stock Information
Price: $3.27   Change: + 0.03
Jul 30, 2014 2:57 PM ET
Investor Relations
Stock price graph

ZIOPHARM Oncology, Inc. is a biopharmaceutical company focused on the development and commercialization of new cancer therapies.

View all »   RSSRecent Releases

Jul 22, 2014
ZIOPHARM Announces Expansion of Ground-Breaking Synthetic Immuno-Oncology Programs With Intrexon and Clinical Program Update

Jun 18, 2014
ZIOPHARM Oncology to Present at the 9th Annual JMP Securities Healthcare Conference

Jun 25, 2014 at 10:00 AM ET
JMP Securities Healthcare Conference

Mar 28, 2014 at 3:00 PM ET
21st Annual Future Leaders in the Biotech Industry Conference